Problems in products liability likely to arise out of COVID-19

Litigation problems stemming from COVID-19, and common issues surrounding forum non conveniens and failure-to-warn cases

David R. Lira
Christopher T. Aumais

COVID-19 business-interruption claims

Getting around the “virus” exclusion may require a lot of careful reading as language differs between policies

Ricardo Echeverria
Michael J. Bidart

Sexual-harassment litigation in the post-#MeToo era

Understanding the recent changes in sexual-harassment law and seizing the opportunities created by them

Ramit Mizrahi

From Issue: 2020 May

Bristol-Myers Squibb’s impact on class actions

Bristol-Myers Squibb imposed new limitations on specific jurisdiction in mass actions

Robert Fisher

When that which is supposed to heal, does more harm than good

An overview of the doctrinal framework of warning defects as applied to pharmaceutical-injury cases

Natali Shabani

The best and worst employment case law developments of 2019

A brief overview of the most important case law developments that shaped the year in employment law (with a bit of color commentary)

Andrew H. Friedman

From Issue: 2020 May